Krystal Biotech (KRYS) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Krystal Biotech, as the data feed reports them.

Analysts' mean target, 9 analysts
$388.22
30.0% above the price

The 9 analysts reported by the data feed have a mean price target for Krystal Biotech of $388.22, 30.0% above the $298.55 price (range $284.00–$474.00). 16.81% of the float was sold short as of Oct 30, 2026. Institutions hold 100.8% of the shares and insiders 10.6%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$388.22+30.0% vs price
Analysts
9
Short interest
16.81%of float, Oct 30, 2026
Short ratio
11.26 days
Institutions
100.8%
Insiders
10.64%
Beta
0.65

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

9 analysts covering Krystal Biotech, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $298.55.

Analysts' price targets for Krystal Biotech
Mean price target$388.2230.0% above the price (+30.0%)
Median price target$380.0027.3% above the price (+27.3%)
Highest target$474.0058.8% above the price (+58.8%)
Lowest target$284.004.9% below the price (−4.9%)
Analysts with a target9

Ratings this month · 12 analysts

Strong buy 1(8%)Buy 10(83%)Hold 1(8%)
Analysts' ratings of Krystal Biotech this month, by rating
RatingAnalystsShare
Strong buy18%
Buy1083%
Hold18%
Sell00%
Strong sell00%

The feed averages these to 1.25 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Krystal Biotech

Ownership of Krystal Biotech
Held by institutions100.8%601 institutions; percent of shares outstanding
Held by institutions, of the float112.8%
Held by insiders10.64%percent of shares outstanding
Shares outstanding29.63M
Float23.66Mshares available to trade
Insiders' net purchases, six months−118.45K3 purchases (8.19K shares), 7 sales (126.64K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Krystal Biotech
Shares short3.04Mas of Oct 30, 2026
Percent of float16.81%shares short ÷ float
Percent of shares outstanding10.28%shares short ÷ shares outstanding
Short ratio (days to cover)11.26shares short ÷ average daily volume

Krystal Biotech short interest from FINRA, with its history

Trading figures

Trading figures for Krystal Biotech
Beta0.65movement against the market; 1 moves with it
52-week high$382.54
52-week low$202.99
Average volume, 3 months281.12Kshares a day
Average volume, 10 days277.53Kshares a day

Questions and answers

What is the analysts' price target for Krystal Biotech (KRYS)?

As reported by the data feed, the mean price target of the 9 analysts covering Krystal Biotech is $388.22, 30.0% above the latest price of $298.55. The highest target is $474.00 and the lowest $284.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Krystal Biotech stock?

Of the 12 ratings the data feed reports for the current month, 1 are strong buy, 10 buy, 1 hold, 0 sell and 0 strong sell.

How many Krystal Biotech shares are sold short?

As reported by the data feed, 3.04M shares were sold short, 16.81% of the float as of Oct 30, 2026. At the average daily volume that is 11.26 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Krystal Biotech stock?

As reported by the data feed, institutions hold 100.8% of the shares (601 institutions) and insiders 10.6%. There are 29.63M shares outstanding, of which 23.66M are in the float.

How much does Krystal Biotech stock move with the market?

Its beta, as reported by the data feed, is 0.65: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $202.99 and $382.54.

Cite this page

Funkfolio, “Krystal Biotech (KRYS) statistics: analyst targets and short interest”, data as of 17 November 2026. https://funkfolio.com/stock/KRYS/statistics

Underlying data: Yahoo Finance.